inositol has been researched along with Diabetic Angiopathies in 22 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
Excerpt | Relevance | Reference |
---|---|---|
"Mononeuritis (or mononeuritis multiplex) seems to be the result of ischaemia due to intrinsic or extrinsic (altered coagulability) vascular disease." | 2.37 | [Pathogenesis of diabetic neuropathies]. ( Arlot, S; Lalau, JD; Quichaud, J, 1985) |
"Methylguanidine was only approximately 7% as effective as aminoguanidine as an inhibitor of AGE formation from L-lysine and G6P; both compounds were poor inhibitors of AR." | 1.29 | Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. ( Chang, K; Corbett, JA; Currie, MG; Hasan, KS; McDaniel, ML; Misko, TP; Moore, WM; Petrash, JM; Smith, SR; Tilton, RG, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (50.00) | 18.7374 |
1990's | 9 (40.91) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaneko, K | 1 |
Satake, C | 1 |
Izumi, T | 1 |
Tanaka, M | 1 |
Yamamoto, J | 1 |
Asai, Y | 1 |
Sawada, S | 1 |
Imai, J | 1 |
Yamada, T | 1 |
Katagiri, H | 1 |
Kaku, K | 1 |
MENEGHINI, P | 1 |
AVANZI, G | 1 |
Lowe, WL | 1 |
Florkiewicz, RZ | 1 |
Yorek, MA | 1 |
Spanheimer, RG | 1 |
Albrecht, BN | 1 |
Hacibekiroğlu, M | 1 |
Akçay, T | 1 |
Tilton, RG | 1 |
Chang, K | 2 |
Hasan, KS | 1 |
Smith, SR | 1 |
Petrash, JM | 1 |
Misko, TP | 1 |
Moore, WM | 1 |
Currie, MG | 1 |
Corbett, JA | 1 |
McDaniel, ML | 1 |
Bando, Y | 1 |
Ushiogi, Y | 1 |
Toya, D | 1 |
Tanaka, N | 1 |
Fujisawa, M | 1 |
Daumerie-Goffinet, C | 1 |
Lambert, AE | 1 |
Clements, RS | 1 |
Radhakrishnamurthy, B | 1 |
Berenson, GS | 1 |
Pargaonkar, PS | 1 |
Voors, AW | 1 |
Srinivasan, SR | 1 |
Plavidal, F | 1 |
Dolan, P | 1 |
Dalferes, ER | 1 |
Brownlee, M | 1 |
Chakrabarti, S | 1 |
Sima, AA | 1 |
Hotta, N | 1 |
Sano, T | 1 |
Hasegawa, M | 1 |
Inoue, M | 1 |
Doi, K | 1 |
Mio, R | 1 |
Sumino, K | 1 |
Fu, MX | 1 |
Qian, RL | 1 |
Sinclair, SH | 1 |
Nesler, CL | 1 |
Schwartz, SS | 1 |
Winegrad, AI | 1 |
Lalau, JD | 1 |
Arlot, S | 1 |
Quichaud, J | 1 |
Williamson, JR | 1 |
Rowold, E | 1 |
Marvel, J | 1 |
Tomlinson, M | 1 |
Sherman, WR | 1 |
Ackermann, KE | 1 |
Kilo, C | 1 |
Schwarz, D | 1 |
Blasi, A | 2 |
Licciardello, M | 2 |
5 reviews available for inositol and Diabetic Angiopathies
Article | Year |
---|---|
Efficacy of voglibose in type 2 diabetes.
Topics: Atherosclerosis; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Glucos | 2014 |
[Diabetic microangiopathies].
Topics: Basement Membrane; Blood Viscosity; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies | 1978 |
Biochemical derangements in diabetes mellitus.
Topics: Aorta; Basement Membrane; Blood Platelets; Blood Proteins; Carbohydrate Metabolism; Diabetes Mellitu | 1979 |
[Role of polyol-myoinositol metabolic changes in the pathogenesis of diabetic macro-angiopathy].
Topics: Animals; Diabetic Angiopathies; Humans; Inositol; Polymers | 1990 |
[Pathogenesis of diabetic neuropathies].
Topics: Animals; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Neuropathies; Energy Metabolism; Humans; | 1985 |
17 other studies available for inositol and Diabetic Angiopathies
Article | Year |
---|---|
Enhancement of postprandial endogenous insulin secretion rather than exogenous insulin injection ameliorated insulin antibody-induced unstable diabetes: a case report.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Gl | 2019 |
[INDIRECT FIBRINOLYTIC AND ANTICOAGULANT TREATMENT OF THROMBOSIS].
Topics: Anticoagulants; Arteriosclerosis Obliterans; Arteritis; Coronary Disease; Diabetic Angiopathies; Eth | 1964 |
Regulation of growth factor mRNA levels in the eyes of diabetic rats.
Topics: Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Retino | 1995 |
The role of plasma, erythrocyte and platelet myo-inositol levels in the development of diabetic microangiopathy.
Topics: Adult; Blood Platelets; Creatinine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic A | 1994 |
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
Topics: Aldehyde Reductase; Amino Acid Oxidoreductases; Animals; Arginine; Benzothiazoles; Blood Pressure; B | 1993 |
Three diabetic cases of acute dizziness due to initial administration of voglibose.
Topics: Aged; Aged, 80 and over; Cerebral Infarction; Cerebrovascular Circulation; Diabetes Mellitus, Type 2 | 1998 |
Serum-free and protein-bound sugars and cardiovascular complications in diabetes mellitus.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Blood Glucose; Blood Pressure; Cardiovascular Diseas | 1976 |
Glycosylation of proteins and microangiopathy.
Topics: Albuminuria; Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diglycerides; Dogs; Gl | 1992 |
The effect of myo-inositol treatment on basement membrane thickening in the BB/W-rat retina.
Topics: Animals; Basement Membrane; Blood Glucose; Capillaries; Diabetes Mellitus, Type 1; Diabetic Angiopat | 1992 |
[Risk factors of developing diabetic complications].
Topics: Animals; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Retinopathy; Female; Glycoprotei | 1991 |
[Clinical significance of serum myo-inositol analysis in the diabetic complications].
Topics: Animals; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; Gas Chromatography-Mass | 1990 |
Retinopathy in the pregnant diabetic.
Topics: Adult; Blood Flow Velocity; Diabetic Angiopathies; Diabetic Retinopathy; Enzymes; Female; Fluorescei | 1985 |
Banting lecture 1986. Does a common mechanism induce the diverse complications of diabetes?
Topics: Animals; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Ne | 1987 |
Diabetes-induced increases in vascular permeability and changes in granulation tissue levels of sorbitol, myo-inositol, chiro-inositol, and scyllo-inositol are prevented by sorbinil.
Topics: Adolescent; Animals; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Angiopathies; | 1986 |
[Medical therapy of obliterating arteriopathies].
Topics: Arteriosclerosis Obliterans; Diabetic Angiopathies; Gangrene; Humans; Inositol; Niacinamide; Pyridox | 1969 |
[Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Diabetic Angiopathies; Female; Humans; Inositol; Kallikrei | 1966 |
[Research on skin temperature and internal temperature in subjects with obliterating arteriopathy. Action of the association of kallikrein and meso-inositol hexanicotinate].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Body Temperature; Diabetic Angiopathies; Female; Humans; I | 1966 |